nach oben

Current Bladder Dysfunction Reports

Erschienen in:

15.01.2024 | REVIEW

Urodynamics in the Transplant Population

verfasst von: Grace S. Lee, Michelle E. Van Kuiken

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Urodynamic testing (UDS) is a valuable tool for understanding the safety of the lower urinary tract (LUT). The goal of this review is to provide evidence-based indications for use of UDS in both the pre- and post-kidney transplant (KT) settings.

Recent Findings

Pre-transplant bladder cycling with UDS for anuric or oliguric patients is no longer recommended. Instead, UDS aids in identifying LUT anomalies that may require optimization prior to transplant, especially in patients with known urologic etiologies of end-stage renal disease (ERSD). In pre-KT patients with recurrent urinary tract infections (UTIs) or prior urologic/pelvic interventions, UDS should be used judiciously when the etiology of LUT dysfunction is unclear. In the post-transplant setting, urologists are often consulted for LUT symptoms (LUTS), hydronephrosis, urinary retention, declining renal function, and most commonly, recurrent UTI. Again, UDS should not be routinely performed first line, but as an adjunct to distinguish similarly presenting LUT etiologies such as bladder outlet obstruction (BOO) and bladder dysfunction.

Summary

UDS remains the gold standard for characterizing the LUT, and when utilized appropriately, can identify factors promoting graft and patient survival after KT.

Sackett DD, Singh P, Lallas CD. Urological involvement in renal transplantation. Int J Urol. 2011;18(3):185–93. https://doi.org/10.1111/j.1442-2042.2010.02707.x.CrossRefPubMed

2.•

Rosier PFWM, Schaefer W, Lose G, et al. International continence society good urodynamic practices and terms 2016: urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn. 2017;36(5):1243–60. https://doi.org/10.1002/nau.23124. Represent fundamental societal guidelines upon which this review is framed.

Rovner ES, Koski ME. Rapid and practical interpretation of urodynamics. Springer; 2014.

Chapple CR, Hillary CJ, Patel A, MacDiarmid SA. Urodynamics made easy: urodynamics made easy e-book. Elsevier Health Sciences; 2018.

Abrams P, Klevmark B. Frequency volume charts: an indispensable part of lower urinary tract assessment. Scand J Urol Nephrol Suppl. 1996;179:47–53.PubMed

Mcguire EJ, Woodside JR. Diagnostic advantages of fluoroscopic monitoring during urodynamic evaluation. J Urol. 1981;125(6):830–4.CrossRefPubMed

Cowan, Nick G Hans A. Renal transplant, AUA core curriculum. Published online March 3, 2023. https://university.auanet.org/core/renal-transplant/renal-transplant/index.cfm?&AUAID=01025540. Accessed 15 Sept 2023.

Silva DM, Prudente AC, Mazzali M, Borges CF, D’Ancona C. Bladder function evaluation before renal transplantation in nonurologic disease: is it necessary? Urology. 2014;83(2):406–10. https://doi.org/10.1016/j.urology.2013.09.015.CrossRefPubMed

Kennedy A, Rice MK, Waguespack M, Xie WY, Al-Qaoud T, Malik RD. A contemporary evaluation of urological outcomes after renal transplantation. Urol Pract. 2023;10(1):75–81. https://doi.org/10.1097/UPJ.0000000000000353.CrossRefPubMed

10.

Tangpaitoon T, Swatesutipun V. Factors associated with low-compliance bladder in end-stage renal disease patients and development of a clinical prediction model for urodynamic evaluation: the DUDi score. Int Urol Nephrol. 2023;55(1):75–84.CrossRefPubMed

11.

Zermann DH, Löffler U, Reichelt O, Wunderlich H, Wilhelm S, Schubert J. Bladder dysfunction and end stage renal disease. Int Urol Nephrol. 2003;35(1):93–7. https://doi.org/10.1023/a:1025910025216.CrossRefPubMed

12.

Song M, Park J, Kim YH, et al. Bladder capacity in kidney transplant patients with end-stage renal disease. Int Urol Nephrol. 2015;47(1):101–6. https://doi.org/10.1007/s11255-014-0848-1.CrossRefPubMed

13.

Chen JL, Lee MC, Kuo HC. Reduction of cystometric bladder capacity and bladder compliance with time in patients with end-stage renal disease. J Formos Med Assoc. 2012;111(4):209–13. https://doi.org/10.1016/j.jfma.2011.09.023.CrossRefPubMed

14.

Turunc T, Micozkadioglu H, Dirim A, et al. Evaluation of video-urodynamic studies before renal transplantation in chronic renal failure patients. Int Urol Nephrol. 2010;42(4):903–7. https://doi.org/10.1007/s11255-010-9739-2.CrossRefPubMed

15.

Vaidya SR, Aeddula NR. Chronic kidney disease. In: StatPearls. StatPearls Publishing, Treasure Island (FL); 2023.

16.

Jha V, Garcia Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–72. https://doi.org/10.1016/S0140-6736(13)60687-X.CrossRefPubMed

17.

Burrows NR, Koyama A, Pavkov ME. Reported cases of end-stage kidney disease—United States, 2000–2019. Am J Transplant. 2022;22(5):1483–6.CrossRef

18.

Serrano DP, Flechner SM, Modlin CS, Wyner LM, Novick AC. Transplantation into the long-term defunctionalized bladder. J Urol. 1996;156(3):885–8. https://doi.org/10.1016/S0022-5347(01)65648-9.CrossRefPubMed

19.

Inoue T, Satoh S, Obara T, et al. Cystometric evaluation of recovery in hypocompliant defunctionalized bladder as a result of long-term dialysis after kidney transplantation. Int J Urol. 2016;23(8):694–700. https://doi.org/10.1111/iju.13122.CrossRefPubMed

20.

Alam Z, VanderBrink BA, Brewer N, et al. Is anuria prior to pediatric renal transplantation associated with poor allograft outcomes? Pediatr Transplant. 2019;23(5):e13453. https://doi.org/10.1111/petr.13453.CrossRefPubMed

21.

Chun JM, Jung GO, Park JB, et al. Renal transplantation in patients with a small bladder. Transplant Proc. 2008;40(7):2333–5. https://doi.org/10.1016/j.transproceed.2008.06.028.CrossRefPubMed

22.

Neves Neto JF, Palomino Z, Mizuno Watanabe IK, Aguiar WF, Medina-Pestana JO, Soler R. Pretransplant defunctionalized bladder—overrated condition? Neurourol Urodyn. 2018;37(5):1559–66. https://doi.org/10.1002/nau.23495.CrossRefPubMed

23.

Osman Y, Zahran MH, Harraz AM, Mashaly M, Kamal AI, Ali-El-Dein B. Utility of pre-transplant bladder cycling for patients with a defunctionalized bladder. a randomized controlled trial. Urology. 2023;174:172–8. https://doi.org/10.1016/j.urology.2023.01.008.CrossRefPubMed

24.

Cerilli J, Anderson GW, Evans WE, Smith JP. Renal transplantation in patients with urinary tract abnormalities. Surgery. 1976;79(3):248–52.PubMed

25.

Hendren WH. Urinary tract re-functionalization after long-term diversion. A 20-year experience with 177 patients. Ann Surg. 1990;212(4):478–95.CrossRefPubMedPubMedCentral

26.

Ross JH, Kay R, Novick AC, Hayes JM, Hodge EE, Streem SB. Long-term results of renal transplantation into the valve bladder. J Urol. 1994;151(6):1500–4. https://doi.org/10.1016/S0022-5347(17)35286-2.CrossRefPubMed

27.

Harada R, Hamasaki Y, Okuda Y, Hamada R, Ishikura K. Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies. Pediatr Nephrol. 2022;37(6):1215–29. https://doi.org/10.1007/s00467-021-05145-1.CrossRefPubMed

28.

Smith JM, Stablein DM, Munoz R, Hebert D, McDonald RA. Contributions of the transplant registry: the 2006 annual report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)*. Pediatr Transplant. 2007;11(4):366–73. https://doi.org/10.1111/j.1399-3046.2007.00704.x.CrossRefPubMed

29.

Marchal S, Kalfa N, Iborra F, et al. Long-term outcome of renal transplantation in patients with congenital lower urinary tract malformations: a multicenter study. Transplantation. 2020;104(1):165. https://doi.org/10.1097/TP.0000000000002746.CrossRefPubMed

30.

Jahromi MS, Velasquez MC, Blachman-Braun R, et al. Pediatric kidney transplantation outcomes in children with primary urological abnormalities versus nonurological abnormalities: long-term results. J Urol. 2020;203(2):406–12. https://doi.org/10.1097/JU.0000000000000528.CrossRefPubMed

31.

Morita K, Iwami D, Hotta K, et al. Pediatric kidney transplantation is safe and available for patients with urological anomalies as well as those with primary renal diseases. Pediatr Transplant. 2009;13(2):200–5. https://doi.org/10.1111/j.1399-3046.2008.00992.x.CrossRefPubMed

32.

Cornwell LB, Ingulli EG, Mason MD, Ewing E, Riddell JV. Renal transplants due to congenital anomalies of the kidney and urinary tract (CAKUT) have better graft survival than non-CAKUT controls: analysis of over 10,000 patients. Urology. 2021;154:255–62. https://doi.org/10.1016/j.urology.2021.01.005.CrossRefPubMed

33.

Evans-Barns H, Mushtaq I, Michell I, Kausman J, Webb N, Taghavi K. Paediatric kidney transplantation: towards a framework for pretransplant urological evaluation. Pediatr Transplant. 2022;26(7):e14299. https://doi.org/10.1111/petr.14299.CrossRefPubMed

34.

Amesty MV, García-Vaz C, Espinosa L, Martínez-Urrutia MJ, López-Pereira P. Long-term renal transplant outcome in patients with posterior urethral valves. Prognostic factors related to bladder dysfunction management. Front Pediatr. 2021;9. https://www.frontiersin.org/articles/10.3389/fped.2021.646923. Accessed 6 Aug 2023.

35.

Sharma A, Ramanathan R, Posner M, Fisher RA. Pediatric kidney transplantation: a review. Transpl Res Risk Manag. 2013;5:21–31. https://doi.org/10.2147/TRRM.S34043.CrossRef

36.

Mariotto A, Cserni T, Marei Marei M, Tavakoli A, Goyal A. Bladder salvage in children with congenital lower urinary tract malformations undergoing renal transplant. J Pediatr Urol. 2023;19(4):401.e1-401.e7. https://doi.org/10.1016/j.jpurol.2023.04.015.CrossRefPubMed

37.

Kim JK, Lorenzo AJ, Raveendran L, et al. Utility of pre-transplant lower urinary tract investigation in pediatric renal transplant population after referral: a 16-year institutional experience. Pediatr Transplant. 2021;25(4):e14006. https://doi.org/10.1111/petr.14006.CrossRefPubMed

38.•

Chadban SJ, Ahn C, Axelrod DA, et al. KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation. 2020;104(4S1):S11. https://doi.org/10.1097/TP.0000000000003136. Represent fundamental societal guidelines upon which this review is framed.

39.

Goldman JD, Julian K. Urinary tract infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13507. https://doi.org/10.1111/ctr.13507.CrossRefPubMed

40.

Anger J, Lee U, Ackerman AL, et al. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol. 2019;202(2):282–9. https://doi.org/10.1097/JU.0000000000000296.CrossRefPubMed

41.

Baskin LS. Handbook of pediatric urology. Lippincott Williams & Wilkins; 2018.

42.

Lobo N, Kulkarni M, Hughes S, Nair R, Khan MS, Thurairaja R. Urologic complications following pelvic radiotherapy. Urology. 2018;122:1–9. https://doi.org/10.1016/j.urology.2018.07.017.CrossRefPubMed

43.

Chen RC, Basak R, Meyer AM, et al. Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA. 2017;317(11):1141–50. https://doi.org/10.1001/jama.2017.1652.CrossRefPubMedPubMedCentral

44.

Wu JM, Gandhi MP, Shah AD, Shah JY, Fulton RG, Weidner AC. Trends in inpatient urinary incontinence surgery in the USA, 1998–2007. Int Urogynecology J. 2011;22(11):1437–43. https://doi.org/10.1007/s00192-011-1509-x.CrossRef

45.

Chughtai B, Sedrakyan A, Isaacs AJ, et al. National study of utilization of male incontinence procedures. Neurourol Urodyn. 2016;35(1):74–80. https://doi.org/10.1002/nau.22683.CrossRefPubMed

46.

Yao HHI, Hoe V, Shamout S, et al. Impact of radiotherapy for localized prostate cancer on bladder function as demonstrated on urodynamics study: a systematic review. Can Urol Assoc J. 2021;15(12):E664–71. https://doi.org/10.5489/cuaj.7265.CrossRefPubMedPubMedCentral

47.

Aponte MM, Shah SR, Hickling D, Brucker BM, Rosenblum N, Nitti VW. Urodynamics for clinically suspected obstruction after anti-incontinence surgery in women. J Urol. 2013;190(2):598–602. https://doi.org/10.1016/j.juro.2013.03.113.CrossRefPubMed

48.

Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK. Renal transplantation in elderly patients older than 70 years of age: results from the scientific registry of transplant recipients. Transplantation. 2007;83(8):1069. https://doi.org/10.1097/01.tp.0000259621.56861.31.CrossRefPubMed

49.

Churchill BM, Gilmour RF, Williot P. Urodynamics. Pediatr Clin North Am. 1987;34(5):1133–57.CrossRefPubMed

50.

Akbar SA, Jafri SZH, Amendola MA, Madrazo BL, Salem R, Bis KG. Complications of renal transplantation. Radiographics. 2005;25(5):1335–56. https://doi.org/10.1148/rg.255045133.CrossRefPubMed

51.

Whang M, Yballe M, Geffner S, Fletcher HS, Palekar S, Mulgaonkar S. Urologic complications in more than 2500 kidney transplantations peformed at the Saint Barnabas healthcare system. Transplant Proc. 2011;43(5):1619–22. https://doi.org/10.1016/j.transproceed.2011.02.014.CrossRefPubMed

52.

Dmochowski RR. Bladder outlet obstruction: etiology and evaluation. Rev Urol. 2005;7(Suppl 6):S3–13.PubMedPubMedCentral

53.

Stoffel JT, Peterson AC, Sandhu JS, Suskind AM, Wei JT, Lightner DJ. AUA white paper on nonneurogenic chronic urinary retention: Consensus definition, treatment algorithm, and outcome end points. J Urol. 2017;198(1):153–60. https://doi.org/10.1016/j.juro.2017.01.075.

54.

Coyne KS, Wein AJ, Tubaro A, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int. 2009;103:4–11.CrossRefPubMed

55.

Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol. 2024;211(1):11–9.

56.

EAU Guidelines. Edn. presented at the EAU Annual Congress Milan; 2023.

57.

Lewis AL, Young GJ, Selman LE, et al. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT. Health Technol Assess Winch Engl. 2020;24(42):1–122. https://doi.org/10.3310/hta24420.CrossRef

58.

Righetto M, Mancini M, Modonutti D, Calpista A, Beltrami P, Dal Moro F. Patients with renal transplant and moderate-to-severe LUTS benefit from urodynamic evaluation and early transurethral resection of the prostate. World J Urol. 2021;39(12):4397–404. https://doi.org/10.1007/s00345-021-03799-y.CrossRefPubMedPubMedCentral

59.

Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant. 2006;20(4):401–9.CrossRefPubMed

60.

Alangaden GJ. Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep. 2007;9(6):475–9.CrossRefPubMed

61.

Veroux M, Giuffrida G, Corona D, Gagliano M, Scriffignano V, Vizcarra D, et al. Infective complications in renal allograft recipients: epidemiology and outcome. In: Transplantation proceedings, vol. 40, no. 6. Elsevier; 2008. pp. 1873–6.

62.

Britt NS, Hagopian JC, Brennan DC, et al. Effects of recurrent urinary tract infections on graft and patient outcomes after kidney transplantation. Nephrol Dial Transplant. 2017;32(10):1758–66. https://doi.org/10.1093/ndt/gfx237.CrossRefPubMed

63.

Lim JH, Cho JH, Lee JH, et al. Risk factors for recurrent urinary tract infection in kidney transplant recipients. Transplant Proc. 2013;45(4):1584–9. https://doi.org/10.1016/j.transproceed.2012.12.011.CrossRefPubMed

64.

Pesce F, Martino M, Fiorentino M, et al. Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study. J Nephrol. 2019;32:661–8.CrossRefPubMed

65.

Mitra S, Alangaden GJ. Recurrent urinary tract infections in kidney transplant recipients. Curr Infect Dis Rep. 2011;13(6):579–87. https://doi.org/10.1007/s11908-011-0210-z.CrossRefPubMed

66.

Halskov ACL, Dagnæs-Hansen J, Stroomberg HV, Sørensen SS, Røder A. Incidence of and risk factors for recurrent urinary tract infections in renal transplant recipients. Eur Urol Open Sci. 2023;52:115–22. https://doi.org/10.1016/j.euros.2023.04.001.CrossRefPubMedPubMedCentral

67.

Hollyer I, Ison MG. The challenge of urinary tract infections in renal transplant recipients. Transpl Infect Dis. 2018;20(2):e12828.CrossRefPubMed

68.

Tawab KA, Gheith O, Al Otaibi T, et al. Recurrent urinary tract infection among renal transplant recipients: risk factors and long-term outcome. Exp Clin Transpl. 2017;15(2):157–63.

69.

Camargo LF, Esteves ABA, Ulisses LRS, Rivelli GG, Mazzali M. Urinary tract infection in renal transplant recipients: incidence, risk factors, and impact on graft function. Transplant Proc. 2014;46(6):1757–9. https://doi.org/10.1016/j.transproceed.2014.05.006.CrossRefPubMed

70.

Papasotiriou M, Savvidaki E, Kalliakmani P, et al. Predisposing factors to the development of urinary tract infections in renal transplant recipients and the impact on the long-term graft function. Ren Fail. 2011;33(4):405–10. https://doi.org/10.3109/0886022X.2011.568137.CrossRefPubMed

71.

Cameron AP, Campeau L, Brucker BM, et al. Best practice policy statement on urodynamic antibiotic prophylaxis in the non-index patient. Neurourol Urodyn. 2017;36(4):915–26. https://doi.org/10.1002/nau.23253.CrossRefPubMed

72.

Theodorou C, Katsifotis C, Bocos J, Moutzouris G, Stournaras P, Kostakis A. Urodynamics prior to renal transplantation. Scand J Urol Nephrol. 2003;37(4):335–8. https://doi.org/10.1080/00365590310001674.CrossRefPubMed

73.

Antoniewicz AA, Zapała Ł, Bogucki A, Małecki R. The standard of urological consultation of patients qualified for renal transplant – a review. Cent Eur J Urol. 2015;68(3):376–82. https://doi.org/10.5173/ceju.2015.551.CrossRef

74.

Kapral N, Kern NG, Corbett ST, et al. Viability of contrast-enhanced voiding urosonography as an alternative to fluoroscopy during video urodynamics. Pediatr Radiol. 2023;53:1713–9. https://doi.org/10.1007/s00247-023-05619-4.

75.

Roic AC, Milošević D, Turudić D, Roic G. An innovative diagnostic procedure in children: videourodynamics with contrast-enhanced voiding urosonography. J Ultrasound. 2023;26(2):583–7. https://doi.org/10.1007/s40477-022-00721-z.CrossRefPubMed

76.

Hutchison D, Sobrado S, Corbett S, et al. Parental perception of contrast enhanced voiding ultrasonography urodynamics vs fluoroscopic urodynamics. J Pediatr Urol: Published online; 2023.CrossRef

77.•

Drake MJ, Doumouchtsis SK, Hashim H, Gammie A. Fundamentals of urodynamic practice, based on International Continence Society good urodynamic practices recommendations. Neurourol Urodyn. 2018;37(S6):S50–60. https://doi.org/10.1002/nau.23773. Represent fundamental societal guidelines upon which this review is framed.

Titel: Urodynamics in the Transplant Population
verfasst von: Grace S. Lee
Michelle E. Van Kuiken
Publikationsdatum: 15.01.2024
Verlag: Springer US
Erschienen in: Current Bladder Dysfunction Reports / Ausgabe 1/2024
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-023-00728-0

Overactive Bladder: the Patient Perspective

REVIEW

Gene Therapy and Overactive Bladder

REVIEW

Using Pictures Instead of Words: Visual-Validated Questionnaires for LUTS and Neurogenic Bladder

Review

In the Era of Holmium Laser Enucleation of the Prostate Is Preoperative Urodynamics Required for Men in Urinary Retention?

Review

Machine Learning and Artificial Intelligence to Improve Interpretation of Urodynamics

Review

Interstitial Cystitis/Bladder Pain Syndrome: Role of Bladder Inflammation in Bladder Function

REVIEW

Neu im Fachgebiet Urologie

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

15.01.2025
Urothelkarzinom
Nachrichten

Sind Menschen mit muskelinvasivem Urothelkarzinom für die neoadjuvante platinbasierte Therapie nicht geeignet oder sprechen sie darauf nicht gut an, ist Pembrolizumab eine adjuvante Alternative: Die krankheitsfreie Lebenszeit wird dadurch mehr als verdoppelt.

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

14.01.2025
Nierenkarzinom
Nachrichten

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Auf weichem Fahrradsattel ist nicht gut Kinder zeugen

14.01.2025
Erektile Dysfunktion
Nachrichten

Männer, die sich gern sportlich verausgaben, riskieren möglicherweise, fürs Vaterwerden nicht genug Kräfte übrig zu haben. In einer Studie fanden sich dafür zwar allenfalls schwache Anzeichen. Es gab jedoch eine Ausnahme.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

14.01.2025
Prostatakarzinom
Nachrichten

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Urodynamics in the Transplant Population

Abstract

Purpose of Review

Recent Findings

Summary

Weitere Artikel der Ausgabe 1/2024

Overactive Bladder: the Patient Perspective

Gene Therapy and Overactive Bladder

Using Pictures Instead of Words: Visual-Validated Questionnaires for LUTS and Neurogenic Bladder

In the Era of Holmium Laser Enucleation of the Prostate Is Preoperative Urodynamics Required for Men in Urinary Retention?

Machine Learning and Artificial Intelligence to Improve Interpretation of Urodynamics

Interstitial Cystitis/Bladder Pain Syndrome: Role of Bladder Inflammation in Bladder Function

Neu im Fachgebiet Urologie

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Auf weichem Fahrradsattel ist nicht gut Kinder zeugen

Vorteile für Androgenentzug plus Androgenrezeptorblockade

Update Urologie

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten